Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Ashmit Kumar

    Jump to

    • Supreme Court reserves its order in emission norms case; verdict on Mar 29

    • EPCA opposes sale of BS-III vehicles beyond April 1; SC to hear appeal on Mar 24

    • Banks seek contempt action in SC against Vijay Mallya

    • SC panel indicts former CBI chief Sinha in coal scam case

    • Subrata Roy's parole extended, SC gives nod to Qatar deal

    • Money from broadcast rights can't be disclosed: BCCI to SC

    • Delhi HC stays ban on 344 drugs; interim relief for pharma cos

    • Probe 21 ecomm cos for FDI violation: Delhi HC tells govt

    • NJAC Challenge: Questionable Appointments!

    • Will surpass 12th five year plan target: NTPC

    • Bajaj Auto's new Pulsar AS 200 priced at Rs 91,500

    • Delhi HC lifts stay on bidding for Chattisgarh coal blocks

    • Union Budget 2015: Apply GAAR prospectively, say experts

    • Will year 2015 offer relief for Sahara's Subrata Roy?

    • Sahara's bid to sell Bank of China's loan faces Sebi hurdle

    • Things falling faster for Sahara‘s Subrata Roy

    • 2G case: All accused directed to appear before court in Mar

    • Zen Firefox takes Smartphone market by storm with U-105

    • DLF moves SC against cancelled Haryana land allotment

    • More burden on India Inc as compliance fears haunt CEOs

    • Vodafone tax row: Bombay High Court raps taxman

    • Bombay Dyeing gets HC nod, can handover land at 1 location

    • Sebi softens stance, approves Gillette‘s MPS formula

      In a departure from its usual stance, Sebi has granted its approval for SK Poddar – the Indian partner‘s shareholding to be classified as public shareholding.

    • Bombay HC grants Idea relief in Rs 1500 cr tax case

      In April this year, the I-T Department had slapped tax notice on Idea Cellular and its subsidiary, Aditya Birla Telecom respectively, in relation to transfer of assets and licences between the two companies in 2009.

    • Johnson & Johnson seeks relief from HC on Maha FDA order

      In a bid to challenge the Maharashtra FDA decision to cancel license to manufacture cosmetics from the Mulund facility, Johnson and Johnson has moved the Bombay HC, reports CNBC-TV18's Ashmit Kumar.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347